N-(1-(cyclohexylamino)-2-methyl-1-oxopropan-2-yl)-N-(6-(hydroxyamino)-6-oxohexyl)benzamide

ID: ALA4060958

Chembl Id: CHEMBL4060958

PubChem CID: 137637989

Max Phase: Preclinical

Molecular Formula: C23H35N3O4

Molecular Weight: 417.55

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C(=O)NC1CCCCC1)N(CCCCCC(=O)NO)C(=O)c1ccccc1

Standard InChI:  InChI=1S/C23H35N3O4/c1-23(2,22(29)24-19-14-8-4-9-15-19)26(17-11-5-10-16-20(27)25-30)21(28)18-12-6-3-7-13-18/h3,6-7,12-13,19,30H,4-5,8-11,14-17H2,1-2H3,(H,24,29)(H,25,27)

Standard InChI Key:  CXPBQHQPEKJZGP-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4060958

    ---

Associated Targets(Human)

HDAC1 Tclin Histone deacetylase 1/2/3/6 (89 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2780cisR (133 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A2780 (11979 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAL-27 (814 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 417.55Molecular Weight (Monoisotopic): 417.2628AlogP: 3.42#Rotatable Bonds: 10
Polar Surface Area: 98.74Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 8.91CX Basic pKa: CX LogP: 3.05CX LogD: 3.04
Aromatic Rings: 1Heavy Atoms: 30QED Weighted: 0.31Np Likeness Score: -0.49

References

1. Krieger V, Hamacher A, Gertzen CGW, Senger J, Zwinderman MRH, Marek M, Romier C, Dekker FJ, Kurz T, Jung M, Gohlke H, Kassack MU, Hansen FK..  (2017)  Design, Multicomponent Synthesis, and Anticancer Activity of a Focused Histone Deacetylase (HDAC) Inhibitor Library with Peptoid-Based Cap Groups.,  60  (13): [PMID:28574690] [10.1021/acs.jmedchem.7b00197]

Source